{"id":58090,"date":"2024-08-08T12:04:32","date_gmt":"2024-08-08T12:04:32","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/08\/08\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/"},"modified":"2024-08-08T12:04:32","modified_gmt":"2024-08-08T12:04:32","slug":"ocuphire-pharma-to-present-at-two-investor-conferences-in-august","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/","title":{"rendered":"Ocuphire Pharma to Present at Two Investor Conferences in August"},"content":{"rendered":"<div>\n<p align=\"left\">FARMINGTON HILLS, Mich., Aug.  08, 2024  (GLOBE NEWSWIRE) &#8212; Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of patients with retinal and refractive eye disorders, today announced that George Magrath, M.D., M.B.A., M.S., Chief Executive Officer, will present at the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=t-Nw1X8Wc3o1tpLO6IDf2m4LwulMIG7MFXwc2mPCcBPZEmBui_7wrT885KNhLisfWBkhhiDwR8XAr-KkRoAdcPlklqhUE5nbjnxnYJ5rAEvmOxNddrQdulklsjn-pk8jVqOee8l-4DoQ3MO7Z6E6oq2uqu2cZFehRPNmkXSQOxXs_kgPZBFOgcglWsUEQvYhnMsRYY97NdC50dmZdPdp2ZvbvOzaLBtH_NP215NgSTA=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\">Canaccord Genuity 44<sup>th<\/sup> Annual Growth Conference<\/a>, to take place in Boston, MA, August 14, 2024, and at the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=biMzDrbHMSneHuwsoQSIBT9Ah2BMhLUksD91GOlT_OJGsaeKGb5gvX5TNZ7K5-qMYS69WCjcFLuKsHt5psz8PN2Fv6dxG_AFsz6Oe60avyZDOYKrrXrmE14JpuVAotBwePXxHgTTWc97zfmQAe9MthH5S-UbMYDsvIGUHhLfYUaB3sS6Dd4ZLIecGz76gBYL\" rel=\"nofollow noopener\" target=\"_blank\" title=\"H.C. Wainwright 4th Annual Ophthalmology Virtual Conference\">H.C. Wainwright 4th Annual Ophthalmology Virtual Conference<\/a>, to take place virtually, on August 15, 2024.<\/p>\n<table style=\"border-collapse: collapse; width:981.812px; border-collapse:collapse ;\">\n<tr>\n<td style=\"max-width:20%; width:196.359px; min-width:20%;;vertical-align: bottom ; \"><strong>Event:<\/strong><\/td>\n<td style=\"max-width:80%; width:785.438px; min-width:80%;;vertical-align: bottom ; \">Canaccord Genuity 44<sup>th<\/sup> Annual Growth Conference<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:20%; width:196.359px; min-width:20%;;vertical-align: bottom ; \"><strong>Location:<\/strong><\/td>\n<td style=\"max-width:80%; width:785.438px; min-width:80%;;vertical-align: bottom ; \">Boston, MA<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \"><strong>Presenter:<\/strong><\/td>\n<td style=\"vertical-align: bottom ; \">Dr. George Magrath<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \"><strong>Date:<\/strong><\/td>\n<td style=\"vertical-align: bottom ; \">August 14, 2024<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \"><strong>Time:<\/strong><\/td>\n<td style=\"vertical-align: bottom ; \">9:00 a.m. ET<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \"><strong>Format:<\/strong><\/td>\n<td style=\"vertical-align: bottom ; \">Fireside Chat<\/td>\n<\/tr>\n<\/table>\n<p><\/p>\n<table style=\"border-collapse: collapse; width:981.812px; border-collapse:collapse ;\">\n<tr>\n<td style=\"max-width:20%; width:196.359px; min-width:20%;;vertical-align: bottom ; \"><strong>Event:<\/strong><\/td>\n<td style=\"max-width:80%; width:785.438px; min-width:80%;;vertical-align: bottom ; \">H.C. Wainwright 4<sup>th<\/sup> Annual Ophthalmology Virtual Conference<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:20%; width:196.359px; min-width:20%;;vertical-align: bottom ; \"><strong>Location:<\/strong><\/td>\n<td style=\"max-width:80%; width:785.438px; min-width:80%;;vertical-align: bottom ; \">Virtual<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \"><strong>Presenter:<\/strong><\/td>\n<td style=\"vertical-align: bottom ; \">Dr. George Magrath<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \"><strong>Date:<\/strong><\/td>\n<td style=\"vertical-align: bottom ; \">August 15, 2024<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \"><strong>Time:<\/strong><\/td>\n<td style=\"vertical-align: bottom ; \">10:30 a.m. ET<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \"><strong>Format:<\/strong><\/td>\n<td style=\"vertical-align: bottom ; \">Presentation<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">\u00a0<\/td>\n<td style=\"vertical-align: bottom ; \">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>Company management will also be available for one-on-one meetings throughout the conferences. If you are interested in arranging a meeting, please contact your conference representative or send an email to ir@ocuphire.com.<\/p>\n<p><strong>About Ocuphire Pharma<\/strong><\/p>\n<p>Ocuphire Pharma, Inc. (Nasdaq: OCUP) is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing novel therapies for the treatment of patients with retinal and refractive eye disorders. Ocuphire\u2019s lead product candidate, APX3330, a novel small-molecule inhibitor of Ref-1 (reduction oxidation effector factor-1 protein), is in development for diabetic retinopathy. In addition, Ocuphire\u2019s late-stage product candidate Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist designed to reduce pupil size, is being developed for presbyopia and dim (mesopic) light vision disturbances and is currently approved and marketed by our partner as RYZUMVI&#x2122; for reversal of pharmacologically induced mydriasis. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=v9T2Asncg-zhCR1tP_58_-cOZealhHb4hB-_P_9LasYIPuC0B2s3yNb4XZzu7k0yXfstmkOhsASgZBUrH83vDq-BFeVu4w7r9tR98jAV45Db2Bzc_gu6pQ2q9F3ANDQTyvQIn__J7I4R-202Z0NauY6WNALHhE_dgK4Fa1BuW1I3K4u0XLeu5_P6-EVZfVJ41OXZ0lo7a3tG6PPB5yLkgmS7L_E4OK7jKrB9O4UOqTvLa2jaSoUtXZ7d_Z9_wpqZz4j4UfmJ33K6xkbexrZp_m4YK3iLf07tIfaJldKXKplI0PGe3rSjpsPhPKMHaxNK5YPtBkbuIoHgbfV9ZLeLnKf0v7zjxwAJHouKvff4XUA=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.ocuphire.com\">www.ocuphire.com<\/a>.\u00a0<\/p>\n<p><strong>Contacts<\/strong><\/p>\n<table style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\">\n<tr>\n<td style=\"border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: middle ; \">Corporate\u00a0<\/td>\n<td style=\"border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: top ; \">Investor Relations\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: top ; \">Nirav Jhaveri, M.B.A.<br \/>CFO<br \/><a href=\"mailto:ir@ocuphire.com\" rel=\"nofollow noopener\" target=\"_blank\" title=\"ir@ocuphire.com\">ir@ocuphire.com<\/a>\u00a0<\/td>\n<td style=\"border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: top ; \">Corey Davis, Ph.D.\u00a0<br \/>LifeSci Advisors\u00a0<br \/><a href=\"mailto:cdavis@lifesciadvisors.com\" rel=\"nofollow noopener\" target=\"_blank\" title=\"cdavis@lifesciadvisors.com\">cdavis@lifesciadvisors.com<\/a><\/td>\n<\/tr>\n<\/table>\n<p align=\"center\"><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NDQ4NDFmOTctNDA1Yi00Njg0LTk3ZTYtMDI0MmVjOWEyZmIwLTUwMDA3Mzk4OA==\/tiny\/Ocuphire-Pharma.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>FARMINGTON HILLS, Mich., Aug. 08, 2024 (GLOBE NEWSWIRE) &#8212; Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of patients with retinal and refractive eye disorders, today announced that George Magrath, M.D., M.B.A., M.S., Chief Executive Officer, will present at the Canaccord Genuity 44th [&#8230;]\n","protected":false},"author":1,"featured_media":58091,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-58090","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ocuphire Pharma to Present at Two Investor Conferences in August - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ocuphire Pharma to Present at Two Investor Conferences in August\" \/>\n<meta property=\"og:description\" content=\"FARMINGTON HILLS, Mich., Aug. 08, 2024 (GLOBE NEWSWIRE) &#8212; Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical co\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-08T12:04:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/08\/Ocuphire-Pharma.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Ocuphire Pharma to Present at Two Investor Conferences in August\",\"datePublished\":\"2024-08-08T12:04:32+00:00\",\"dateModified\":\"2024-08-08T12:04:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/\"},\"wordCount\":309,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/\",\"name\":\"Ocuphire Pharma to Present at Two Investor Conferences in August - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-08-08T12:04:32+00:00\",\"dateModified\":\"2024-08-08T12:04:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ocuphire Pharma to Present at Two Investor Conferences in August\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ocuphire Pharma to Present at Two Investor Conferences in August - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/","og_locale":"en_US","og_type":"article","og_title":"Ocuphire Pharma to Present at Two Investor Conferences in August","og_description":"FARMINGTON HILLS, Mich., Aug. 08, 2024 (GLOBE NEWSWIRE) &#8212; Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical co","og_url":"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-08-08T12:04:32+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/08\/Ocuphire-Pharma.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Ocuphire Pharma to Present at Two Investor Conferences in August","datePublished":"2024-08-08T12:04:32+00:00","dateModified":"2024-08-08T12:04:32+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/"},"wordCount":309,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/","url":"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/","name":"Ocuphire Pharma to Present at Two Investor Conferences in August - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-08-08T12:04:32+00:00","dateModified":"2024-08-08T12:04:32+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/ocuphire-pharma-to-present-at-two-investor-conferences-in-august\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Ocuphire Pharma to Present at Two Investor Conferences in August"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/58090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=58090"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/58090\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/58091"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=58090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=58090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=58090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}